Alnylam Pharmaceuticals, Inc. SEC filings ALNY
Alnylam Pharmaceuticals, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Sep 12, 2014. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Jun 17, 2025 | — |
| CORRESP | Letter to the SEC | May 22, 2025 | — |
| UPLOAD | Letter from the SEC | May 9, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2024 | — |
| CORRESP | Letter to the SEC | Aug 22, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2024 | — |
| CT ORDER | Filing | Feb 14, 2023 | — |
| SEC STAFF LETTER | Filing | Mar 18, 2021 | — |
| SEC STAFF LETTER | Filing | Feb 18, 2021 | — |
| CT ORDER | Filing | Jul 5, 2019 | — |
| CT ORDER | Filing | May 2, 2019 | — |
| CT ORDER | Filing | May 2, 2019 | — |
| CT ORDER | Filing | May 2, 2019 | — |
| CT ORDER | Filing | Apr 10, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 21, 2019 | — |
| PRER14A | Filing | Mar 18, 2019 | — |
| CT ORDER | Filing | Sep 12, 2018 | — |
| CT ORDER | Filing | Jun 5, 2018 | — |
| CT ORDER | Filing | Jan 24, 2018 | — |
| CT ORDER | Filing | Jan 24, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 23, 2018 | — |
| CORRESP | Letter to the SEC | Jan 19, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 10, 2018 | — |
| CORRESP | Letter to the SEC | Dec 11, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 28, 2017 | — |
| CT ORDER | Filing | Oct 24, 2017 | — |
| CT ORDER | Filing | Sep 12, 2017 | — |
| CT ORDER | Filing | Feb 7, 2017 | — |
| CT ORDER | Filing | May 19, 2016 | — |
| CT ORDER | Filing | Apr 4, 2016 | — |
| CT ORDER | Filing | Mar 9, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2015 | — |
| CORRESP | Letter to the SEC | Dec 9, 2015 | — |
| CT ORDER | Filing | Dec 8, 2015 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2015 | — |
| CT ORDER | Filing | Oct 5, 2015 | — |
| 15-12B | Deregistration | Aug 6, 2015 | — |
| 25 | Form 25 | Jul 27, 2015 | — |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ALNY (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1178670
- Former names
- ALNYLAM PHARMACEUTICALS INC (until Jul 2, 2004)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.